BMO (BMO) Q3 2026 Earnings Call Transcript

BMO reported adjusted net income of $2,859M (+19% YoY) and adjusted EPS of $3.96 (+22% YoY), with ROE rising 200 bps to 14% and CET1 at 13% supported by 33 bps of capital generation net of dividends. Credit costs eased: total provision for credit losses fell to $722M from $797M YoY, with impaired provisions declining and impaired loans PCL at $708M. Capital return and deployment were stepped up via a dividend of $1.71 per share (+5% YoY) plus a new NCIB for up to 25M additional shares (about 3.6% of shares outstanding), while management expects divestitures to add ~50 bps to CET1 on closing and remains on track for a 15% ROE exit target. AI-enabled product rollouts (e.g., SmartDecision underwriting in ~10 seconds vs ~28 industry days) and resilient NIM (226 bps, +5 bps YoY) further support the growth narrative despite tariff/trade uncertainty.

Analysis

The stock should be judged less on the headline beat than on whether the market believes management can now convert capital into growth without sacrificing return on equity. The new buyback authorization matters because it signals the bank is finally in the self-reinforcing phase of the cycle: higher earnings, higher capital generation, then more repurchases. That said, part of the near-term EPS optics are flattered by portfolio pruning, so the key question is whether the remaining franchise can keep growing revenue faster than RWA once the liquidity cushion normalizes.

Relative winners are BMO and, second order, firms tied to North American treasury, payments, and balance-sheet efficiency rather than raw loan volume. If BMO keeps taking share in commercial deposits and fee-heavy TPS, smaller U.S. regionals and slower-moving Canadian peers should feel pressure on pricing and client retention. The more interesting spillover is that trade-policy volatility may actually increase demand for working-capital, hedging, and restructuring services, which benefits capital markets and transaction banking before it shows up in loan growth.

The main risk is not immediate credit, but a delayed macro hit: if tariffs leak into Canadian employment and insolvencies over the next 1-3 quarters, the current benign provision trend can reverse quickly. Another watch item is NIM: if loan growth continues to outrun deposits, the market may start discounting the 15% ROE path as too back-ended. Contrarian takeaway: consensus is likely underestimating how much of the upside is structural expense/capital efficiency rather than cyclical credit improvement, but it may be overestimating how easy it will be to redeploy assets at the same return profile.

Key Decisions for Investors

• Long BMO common on weakness over the next 1-2 sessions; treat the initial move as tradable only if the post-earnings gap holds and management closes the divestiture/buyback loop within 1-3 months.
• Pair trade: long BMO / short RY for 3-6 months to express ROE convergence and capital-return acceleration; thesis breaks if BMO's 4Q NIM or loan-growth guide weakens materially while RY keeps stable credit.
• Buy BMO 3-6 month call spreads only if the stock retraces and implied volatility stays below the post-earnings percentile; target a re-rating as CET1 and buyback cadence become visible.
• Set an alert for 4Q impaired PCL and NIM commentary: if impaireds rise above Q3 or NIM falls >4 bps sequentially, the thesis shifts from 'quality compounder' to 'capital return story with macro risk.'